Keck School of Medicine at USC

Los Angeles, California 90033

0 studies enrolling now · 3 studies all time

What they study most

Acute Antibody-Mediated Rejection (AMR), Idiopathic Pulmonary Fibrosis, Liver Cirrhosis, Biliary

Studies at this site

• A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis — Running, not enrolling
• A Multicenter Study to Evaluate the Efficacy and Safety of Cinryze® for the Treatment of Acute Antibody-mediated Rejection in Participants With Kidney Transplant — Stopped early
• Ursodiol-Methotrexate for Primary Biliary Cirrhosis — Completed